drug-DNA complexes; noncovalent complexes; MS/MS; negative ion mode; gas-phase basicity; mass spectrometry
Abstract :
[en] We report systematic investigation of duplex DNA complexes with minor groove binders (Hoechsts 33258 and 33342, netropsin and DAPI) and intercalators (daunomycin, doxorubicin, actinomycin D, ethidium, cryptolepine, neocryptolepine, m-Amsacrine, proflavine, ellipticine and mitoxantrone) by ESI-MS and ESI-MS/MS in the negative ion mode and in the positive ion mode. The apparent solution phase equilibrium binding constants can be determined by measuring relative intensities in the ESI-MS spectrum. While negative ion mode gives reliable results, positive ion mode gives a systematic underestimation of the binding constants and even a complete suppression of the complexes for intercalators lacking functional groups capable of interacting in the grooves. In the second part of the paper we systematically compare MS/MS fragmentation channels and breakdown curves in the positive and the negative modes, and discuss the possible uses and caveats of MS/MS in drug-DNA complexes. In the negative mode, the drugs can be separated in three groups: (1) those that leave the complex with no net charge; (2) those that leave the complex with a negative charge; and (3) those that remain attached on the strands upon dissociation of the duplex due to their positive charge. In the positive ion mode, all complexes fragment via the loss of protonated drug. Information on the stabilization of the complex by drug-DNA noncovalent interactions can be obtained straightforwardly only in the case of neutral drug loss. In all other cases, proton affinity (in the positive ion mode), gas-phase basicity (in the negative ion mode) and coulombic repulsion are the major factors influencing the fragmentation channel and the dissociation kinetics.
Research center :
CART - Centre Interfacultaire d'Analyse des Résidus en Traces - ULiège
Disciplines :
Chemistry
Author, co-author :
Rosu, Frédéric ; Université de Liège - ULiège > Chimie physique, spectrométrie de masse
Pirotte, Sophie ; Université de Liège - ULiège > Labo de recherche sur les métastases
De Pauw, Edwin ; Université de Liège - ULiège > Chimie physique, spectrométrie de masse
Gabelica, Valérie ; Université de Liège - ULiège > Chimie physique, spectrométrie de masse
Language :
English
Title :
Positive and negative ion mode ESI-MS and MS/MS for studying drug-DNA complexes
Publication date :
2006
Journal title :
International Journal of Mass Spectrometry
ISSN :
1387-3806
Publisher :
Elsevier Science, Amsterdam, Netherlands
Volume :
253
Issue :
3
Pages :
156-171
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Gupta R., Kapur A., Beck J.L., and Sheil M.M. Rapid Commun. Mass Spectrom. 15 (2001) 2472
Gupta R., Beck J.L., Ralph S.F., Sheil M.M., and Aldrich-Wright J.R. J. Am. Soc. Mass Spectrom. 15 (2004) 1382
Gabelica V., De Pauw E., and Rosu F. J. Mass Spectrom. 32 (1999) 1328
Gabelica V., Rosu F., Houssier C., and De Pauw E. Rapid Commun. Mass Spectrom. 14 (2000) 464
Wan K.X., Shibue T., and Gross M.L. J. Am. Soc. Mass Spectrom. 11 (2000) 450
Reyzer M., Brodbelt J.S., Kerwin S.M., and Kumar D. Nucleic Acids Res. 29 (2001) e103
Keller K.M., Zhang J.M., Oehlers L., and Brodbelt J.S. J. Mass Spectrom. 40 (2005) 1362
Cimanga K., De Bruyne T., Pieters L., Vlietinck A.J., and Turger C.A. J. Nat. Prod. 60 (1997) 688
Gabelica V., and De Pauw E. J. Am. Soc. Mass Spectrom. 13 (2002) 91
Gabelica V., and De Pauw E. Int. J. Mass Spectrom. 219 (2002) 151
http://webbook.nist. gov/chemistry/ion/#GB; accessed on 1 May 2005.
Qu X., and Chaires J.B. J. Am. Chem. Soc. 123 (2001) 1
Chaires J.B. Biophys. Chem. 35 (1990) 191
Cech N.B., and Enke C.G. Mass Spectrom. Rev. 20 (2001) 362
Cech N.B., and Enke C.G. Anal. Chem. 73 (2001) 4632
Green-Church K.B., and Limbach P.A. J. Am. Soc. Mass Spectrom. 11 (2000) 24
Nakano S.-I., Fujimoto M., Hara H., and Sugimoto N. Nucleic Acids Res. 27 (1999) 2957
MacDonald D., Herbert K., Zhang X., Polgruto T., and Lu P. J. Mol. Biol. 306 (2001) 1081
Strahs D., and Schlick T. J. Mol. Biol. 301 (2000) 643
Bailly C., Laine W., Baldeyrou B., De Pauw-Gillet M.-C., Colson P., Houssier C., Cimanga K., Van Miert S., Vlietink A.J., and Pieters L. Anticancer Drug Des. 15 (2000) 191
Dassonneville L., Lansiaux A., Wattelet A., Wattez N., Mahieu C., Van Miert S., Pieters L., and Bailly C. Eur. J. Pharmacol. 409 (2000) 9
Lisgarten J.N., Coll M., Portugal J., Wright C.W., and Aymami J. Nat. Struct. Biol. 9 (2002) 57
Gabelica V., and De Pauw E. J. Mass Spectrom. 36 (2001) 397
Frederick C.A., Williams L.D., Ughetto G., Van der Marel G.A., Van Boom J.H., Rich A., and Wang A.H. Biochemistry 29 (1990) 2538